Drug Trial Radar · NCT07427797
A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
309
Actual
Start
Feb 27, 2026
Primary completion
Aug 12, 2026
Study completion Jul 14, 2027
Sponsor
- Lead sponsor
- IpsenIndustry
- Sponsor type
- Industry
- First posted
- Feb 23, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the effectiveness and safety of Corabotase (also known as IPN10200) compared to placebo in the improvement of the appearance of moderate to severe glabellar lines in adult participants. Glabellar lines are wrinkle-like lines that appear between the eyebrows and can become more noticeable with age or repeated facial expressions. They may affect a person's appearance and confidence. In this study, all participants will receive a single injection of either Corabotase or placebo (the study drug). There will be 3 periods in this study: * A screening period (up to 20 days) to assess whether the participant can take part, requiring at least 1 visit to the study centre. * A treatment period (Day 1) where all the eligible participants will receive a single injection of IPN10200 or placebo. * A follow-up period (52 weeks) where participants' health will be monitored, consisting of regular visits to the study centre and 1 telephone call visit. Participants will undergo health measurements and observation, including blood sampling, physical examinations, clinical evaluations and electrocardiograms (ECG: recording of the electrical activity of heart). They will also be asked to fill in questionnaires and keep a diary. Each participant will be in this study for up to 55 weeks. Participants may withdraw consent to participate at any time.
Conditions
- Moderate to Severe Glabellar Lines
Interventions
CorabotaseBiological
A single vial of lyophilised powder for solution for injection will be injected locally into several sites across the glabellar region.
PlaceboBiological
A single vial of lyophilised powder for solution, containing excipients without active substance, will be injected locally into several sites across the glabellar region.
Primary outcomes
What the sponsor says the trial is designed to measure.
- For North America: Percentage of participants responding to treatmentTime frame: From baseline to week 4
- For EU and ROW: Percentage of participants responding to treatmentTime frame: From baseline to week 4
Locations
23 sites in 2 countries. Site status is shown where the registry gives one.
Skin Wellness Dermatology - Homewood
Birmingham, Alabama
Advanced Research Associates
Glendale, Arizona
Avacare
Scottsdale, Arizona
Investigate MD, LLC
Scottsdale, Arizona
Ablon Skin Institute and Research Center
Manhattan Beach, California
Keith A. Marcus, MD Inc
Redondo Beach, California
West Dermatology
San Diego, California
Ava T. Shamban, M.D., Inc.
Santa Monica, California
Art of Skin MD
Solana Beach, California
Pacific Clinical Innovations Inc.
Vista, California
Skin Research Institute
Coral Gables, Florida
ICON Dermatology and Aesthetics
Bethesda, Maryland
Clinical Research Center of the Carolinas
Charleston, South Carolina
Westlake Dermatology & Cosmetic Surgery - Westlake
Austin, Texas
Dermatology and Laser Surgery Center
Houston, Texas
Pflugerville Dermatology Clinical Research Center, Inc. d/b/a Austin Institute for Clinical Research
Pflugerville, Texas
SkinDC
Arlington, Virginia
Carruthers and Humphrey Cosmetic Medicine
Vancouver, British Columbia, Canada
Pacific Dermaesthetics Inc.
Vancouver, British Columbia, Canada
Institute of Cosmetic and Laser Surgery
Oakville, Ontario, Canada
Sweat clinics of canada
Toronto, Ontario, Canada
Bertucci MedSpa
Woodbridge, Ontario, Canada
Centre de Recherche Dermatologique de Quebec
Québec, Quebec, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.